PubChem CID 11646823 ChemSpider 9821562 Molar mass 391.774 g/mol | IUPHAR/BPS 6409 Formula C19H13ClF3N3O | |
 | ||
3D model (Jmol) Interactive imageInteractive image | ||
Ctep por paz pan y trabajo
CTEP is a research drug developed by Hoffmann-La Roche that acts as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR5, binding with nanomolar affinity and over 1000 times selectivity over all other receptor targets tested. In animal studies it was found to have a high oral bioavailability and a long duration of action, lasting 18 hours after a single dose, giving it considerably improved properties over older mGluR5 antagonists such as MPEP and fenobam.
Contents
pueblo en lucha ctep regional
References
CTEP Wikipedia(Text) CC BY-SA